Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nature Immunology|May 27, 2003
Hematopoietic stem cells engraft in mice with absolute efficiencyPatricia Benveniste, Claude Cantin, Deborah Hyam, et al.
Nature Medicine|March 5, 2002
Hematopoietic competence is a rare property of neural stem cells that may depend on genetic and epigenetic alterationsCindi M Morshead, Patricia Benveniste, Norman N Iscove, et al.
Cell Stem Cell|January 16, 2010
Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potentialPatricia Benveniste, Catherine Frelin, Salima Janmohamed, et al.
Blood|December 24, 2013
Notch signals are required for in vitro but not in vivo maintenance of human hematopoietic stem cells and delay the appearance of multipotent progenitorsPatricia Benveniste, Pablo Serra, Dzana Dervovic, et al.
Scientific Reports|August 17, 2021
Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populationsShai Efrati, Merav Catalogna, Ramzia Abu Hamad, et al.
Epidemiology and Infection|March 8, 2021
Presence of SARS-CoV-2 RNA on playground surfaces and water fountainsEran Kozer, Ehud Rinott, Guy Kozer, et al.
Scientific Reports|July 3, 2021
Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patientsShai Efrati, Merav Catalogna, Ramzia Abu Hamed, et al.
Blood|July 28, 2010
Targeted deletion of the tachykinin 4 gene (TAC4-/-) influences the early stages of B lymphocyte developmentAlexandra Berger, Patricia Benveniste, Steven A Corfe, et al.
Developmental Medicine and Child Neurology|May 16, 2014
CYP2D6 genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort studyIlan Youngster, Ditza A Zachor, Lidia V Gabis, et al.
American Journal of Hematology|June 29, 2021
BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignanciesKatrin Herzog Tzarfati, Odit Gutwein, Arie Apel, et al.
Pageof 2